Day: August 18, 2020

Due to the large decline in elective procedures in Interventional Urology and the reversal of stock building in Europe, which took place in the second quarter, Coloplast reports negative organic growth of -2% in the third quarter of the 2019/20 financial year. The company has narrowed its financial guidance range for organic growth for 2019/20 from 4-6% to ~4% due to a weaker outlook for the Wound & Skin Care business and the UK Chronic Care business, and expects an EBIT margin of ~31% from previously 30-31%.“The COVID-19 outbreak had a material negative impact on elective procedures and our Interventional Urology business in the US in the third quarter. Looking ahead, we are encouraged by the pace at which elective procedures resumed across the quarter and we have reinitiated investments into the business,” says Coloplast CEO Kristian...

På grund af det store fald i ikke-akutte urologiske operationer og afviklingen af den lageropbygning i Europa, der fandt sted i Q2, rapporterer Coloplast en negativ organisk vækst på -2% i tredje kvartal af 2019/20-regnskabsåret. Selskabet har præciseret sine finansielle forventninger til den organiske vækst for 2019/20 fra 4-6% til ~4% på grund af svagere udsigter for Hud- og Sårplejeforretningen og for den kroniske forretning i Storbritannien. Coloplast forventer nu en overskudsgrad på ~31% mod tidligere 30-31%.“COVID-19-udbruddet medførte et betydeligt fald i antallet af ikke-akutte operationer, og det har haft en signifikant negativ effekt på vores amerikanske urologiforretning i Q3. Når vi ser fremad giver tempoet for genoptagelsen af ikke-akutte operationer i løbet af kvartalet anledning til optimisme, og vi investerer igen...

Coloplast strengthens Executive Management to deliver on upcoming 2025 strategy centred around innovation and growthToday, the Board of Directors have decided to expand the Executive Leadership Team from four members to six members as of 1 October 2020.The expansion aims to support the upcoming strategy which will focus on innovation and growth. A new Innovation Executive Vice President position position with responsibility for the company’s commercial offering and combining marketing, R&D and select global functions will be led by Nicolai Buhl Andersen. A new Growth Executive Vice President position position which combines the chronic care sales organization and the Wound & Skin care SBU will be led by Paul Marcun. Finally, HR is renamed People & Culture and elevated to the Executive leadership team to be led by Camilla...

Coloplast udvider ledelsesteamet for at levere på den kommende 2025 strategi, fokuseret på innovation og vækstBestyrelsen har i dag besluttet at styrke ledelsesteamet fra fire til seks medlemmer pr. 1. oktober 2020.Udvidelsen skal supportere den kommende strategi, der vil fokusere på innovation og vækst. En ny Executive Vice President stilling for Innovation, med ansvar for virksomhedens kommercielle udbud, med en kombination af marketing, forskning og udvikling og udvalgte globale funktioner, vil blive ledet af Nicolai Buhl Andersen. En ny Executive Vice President stilling for Growth, som kombinerer salgsorganisationen for den kroniske forretning samt og Hud- og Sårplejeforretningen, og blive ledet af Paul Marcun. Dertil omdøbes HR til People & Culture, samt løftes op i Coloplasts øverste ledelse of vil blive ledet af Camilla G....

9M 2019/20Interim financial report, 9M 2019/20(01 October 2019 – 30 June 2020)                   Significant negative impact from COVID-19 in Q3 due to the decline in elective procedures and the reversal of stock building, guidance range for 2019/20 narrowedNegative organic growth of -2% in Q3. Reported revenue in DKK was down by 4% to DKK 4,419m. Year to date organic growth was 5% and reported revenue in DKK increased by 5% to DKK 13,954m.Organic growth rates by business area year to date: Ostomy Care 8%, Continence Care 7%, Interventional Urology -10% and Wound & Skin Care 2%.The Chronic Care business delivered stable underlying growth in Q3, but was adversely impacted by the reversal of the majority of the positive DKK ~150m impact from the previous stock building in mainly Europe. US and EM performed well and the situation...

9M 2019/20Regnskabsmeddelelse, 9M 2019/20(1. oktober 2019 – 30. juni 2020) Betydelig negativ effekt af COVID-19 i tredje kvartal som følge af faldet i ikke-akutte operationer og afvikling af lageropbygning, præcisering af forventningerne til 2019/20Coloplast leverede en negativ organisk vækst på -2% i tredje kvartal. Den rapporterede omsætning, målt i danske kroner, faldt 4% til 4.419 mio. kr. Den organiske omsætningsvækst år til dato var 5%, og målt i danske kroner steg omsætningen ligeledes 5% til 13.954 mio. kr.Den organiske vækst år til dato blev 8% i Stomi, 7% i Kontinens, -10% i Urologi og 2% i Hud- og Sårpleje.Den kroniske forretning leverede en stabil underliggende vækst i tredje kvartal, men blev negativt påvirket af afviklingen af størstedelen af den tidligere lageropbygning, der fandt sted i andet kvartal, primært i Europa,...

VANCOUVER, British Columbia, Aug. 18, 2020 (GLOBE NEWSWIRE) — Liberty Gold Corp. (LGD-TSX) (“Liberty Gold” or the “Company”) is pleased to report results from Phase 2 metallurgical column testing on oxide material from drill core at its Black Pine Project in southeastern Idaho. Gold extractions from 29 variability composites designed to test the full range of rock types and grades encountered in the drill holes were rapid, with >80% of the leachable gold extracted within 10 days, and final column leach gold extractions ranging up to 94.5%.  These results are in-line with and slightly better than Phase 1 bulk sample column test results (78.9% weighted average extraction) and historical column tests from bulk samples and drill core (80.8%) (see press release June 16, 2020).The Phase 2 metallurgical test work continues to provide support...

Highest Q2 Net Income in 20 YearsHighest Quarterly Adjusted EBITDA in Company’s HistoryMINNEAPOLIS, Aug. 18, 2020 (GLOBE NEWSWIRE) — iMedia Brands, Inc. (the “Company”) (NASDAQ: IMBI) today announced results for the second quarter ended August 1, 2020. Second Quarter 2020 Summary & Recent HighlightsNet Income was $1.1 million, compared to a net loss of $10.2 million for Q2 prior year.Adjusted EBITDA was $10.7 million, compared to $0.2 million for Q2 prior year.Net sales were $124.5 million, a decline of 5.3% compared to Q2 prior year.Gross margin was 37.2%, an improvement of 90-basis points compared to Q2 prior year.The quarterly Active Customer file grew 1% year-over-year, which was the first time in four years the Company’s active customer file posted growth for a quarter.ShopHQ launched 25 exciting new brands in Q2 and 15...

MADISON, Wis., Aug. 18, 2020 (GLOBE NEWSWIRE) — Western University of Health Services is nearing 1 million Mediasite views from its students, due to a massive online learning bump during the spring campus shutdown. A significant portion of those views came from students since March alone.  The health professions university, which has campuses in Pomona, Calif. and Lebanon, Ore., pivoted swiftly to virtual learning with a mix of video lectures and collaborative Zoom and Microsoft Teams calls, all available in its learning management systems Blackboard, Canvas and Elentra. As the new school year quickly approaches, the university is planning for all possible scenarios with Mediasite at the heart of its teaching and learning strategy.  “We are planning for a hybrid approach,” said Amber Schaefer, Educational Technology Administrator,...

SHANGHAI, China, Aug. 18, 2020 (GLOBE NEWSWIRE) — Dada Group (NASDAQ: DADA, “Dada” or the “Company”), a leading platform for local on-demand retail and delivery in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2020, on Monday, August 24, 2020, after the close of U.S. markets.The Company will host a conference call to discuss the earnings at 9:00 p.m. Eastern Time on Monday, August 24, 2020 (9:00 a.m. Beijing time on Tuesday, August 25, 2020).Please register in advance of the conference using the link provided below and dial in 10 minutes prior to the call, using participant dial-in numbers, Direct Event passcode and unique registrant ID which would be provided upon registering. You will be automatically linked to the live call after completion of this process, unless...